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Phage-Mediated Acquisition of a Type III Secreted Effector Protein
Boosts Growth of Salmonella by Nitrate Respiration
Christopher A. Lopez, Sebastian E. Winter, Fabian Rivera-Chávez, Mariana N. Xavier, Victor Poon, Sean-Paul Nuccio, Renée M. Tsolis,
and Andreas J. Bäumler
Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, USA
ABSTRACT Information onhow emerging pathogens can invade andpersist and spreadwithin host populations remains sparse. In the
1980s, amultidrug-resistant Salmonella enterica serotype Typhimurium clone lysogenized by a bacteriophage carrying the sopE viru-
lence gene caused an epidemic among cattle andhumans in Europe.Herewe show that phage-mediated horizontal transfer of the sopE
gene enhances the production of host-derived nitrate, an energetically highly valuable electron acceptor, in amouse colitismodel. In
turn, nitrate fuels a bloomof S. Typhimurium in the gut lumen through anaerobic nitrate respirationwhile suppressing genes for the
utilization of energetically inferior electron acceptors such as tetrathionate. Through thismechanism, horizontal transfer of sopE can
enhance the fitness of S. Typhimurium, resulting in its significantly increased abundance in the feces.
IMPORTANCE During gastroenteritis, Salmonella enterica serotype Typhimurium can use tetrathionate respiration to edge out
competing microbes in the gut lumen. However, the concept that tetrathionate respiration confers a growth benefit in the in-
flamed gut is not broadly applicable to other host-pathogen combinations because tetrathionate respiration is a signature trait
used to differentiate Salmonella serotypes frommost other members of the family Enterobacteriaceae. Here we show that by ac-
quiring the phage-carried sopE gene, S. Typhimurium can drive the host to generate an additional respiratory electron acceptor,
nitrate. Nitrate suppresses genes for the utilization of energetically inferior electron acceptors such as tetrathionate while en-
hancing the luminal growth of S. Typhimurium through anaerobic nitrate respiration. Pathways for anaerobic nitrate respira-
tion are widely conserved amongmembers of the family Enterobacteriaceae, thereby making our observations relevant to other
enteric pathogens whose relative abundance in the intestinal lumen increases during infection.
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The first human outbreak of a multidrug-resistant (MDR)pathogen was recorded between 1964 and 1966 in Great Brit-
ain (1). The outbreak was caused by a Salmonella enterica serotype
Typhimurium strain which circulated in cattle and had acquired
resistance to furazolidone, ampicillin, chloramphenicol (Cm),
kanamycin (Kan), neomycin, streptomycin, sulfonamides, and
tetracyclines. Differentiation of S. Typhimurium isolates by phage
typing identified the outbreak strain as a distinct clone with defin-
itive phage type 29 (DT29) (1). Subsequent surveillance by the
Central Veterinary Laboratory in the United Kingdom revealed
the emergence of several MDR clones over time. Each epidemic
clone, after dominating for a period of time in its bovine animal
reservoir, was eventually replaced, as indicated by the dominance
of a new phage type (reviewed in reference 2). However, the rise
and fall of epidemic S. Typhimuriumphage typeswere not accom-
panied by obvious changes in their antibiotic resistance profiles,
suggesting that antibiotic resistance is not the sole property that
enhances the fitness of a newly emergent clone.
Phage types DT204 and DT204c define an epidemic MDR
S. Typhimurium clone which dominated in Europe in the 1980s
(2). Isolates of this clone are lysogenized by a bacteriophage,
termed SopE, which carries the sopE virulence gene (3, 4). The
SopE prophage is present in only a small fraction of S. Typhi-
murium isolates, including phage types DT204, DT204c, and
DT49 and laboratory strain SL1344 (4). Based on the association
of SopE with an epidemic S. Typhimurium clone, it has been
speculated that acquisition of the SopE protein by phage-
mediated horizontal gene transfermight have increased the fitness
of the resulting strain in its host population (5). However, exper-
imental evidence for this hypothesis is lacking.
The sopE gene encodes a secreted substrate (effector protein) of
the invasion-associated type III secretion system (T3SS-1) of
S. Typhimurium (3, 6). SopE activates several innate immune sig-
naling pathways (6–8) and is a potent inducer of intestinal inflam-
mation (9, 10), but the molecular mechanisms by which SopE
might enhance the fitness of an epidemic S. Typhimurium clone
remain unknown. Here we investigated whether SopE increases
the fitness of S. Typhimurium in a mouse colitis model and eluci-
dated the underlying mechanism.
RESULTS
SopE enhances growth in the inflamed intestine. The sopE gene
increases the severity of intestinal inflammation (8, 10), and this
host response enhances the luminal growth of S. Typhimurium
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(11, 12). Based on these observations, we reasoned that SopE
might increase the bacterial numbers in the gut contents.We used
S. Typhimurium strain SL1344 (13), which carries the SopE
prophage (3), to investigate whether acquisition of the sopE gene
enhances the fitness of the pathogen in the mouse colitis model
(14). In this model, genetically susceptible mice (C57BL/6) are
given streptomycin 24 h prior to S. Typhimurium administration.
Treatment of mice with streptomycin prior to bacterial inocula-
tion disrupts the resident microbiota to allow S. Typhimurium to
elicit a pathology similar to human gastroenteritis (14). A previ-
ous study found the SL1344 wild type and a derivative carrying
mutations in invG (resulting in inactivation of T3SS-1) and sseD
(resulting in inactivation of T3SS-2) are recovered in equal num-
bers from intestinal contents during the first 3 days after infection
in the mouse colitis model (12). However, at day 4 after infection,
mice infected with the SL1344 wild type, which elicits intestinal
inflammation, contain significantly higher numbers of S. Typhi-
murium bacteria in their intestinal contents than mice infected
with an invG sseDmutant which does not elicit intestinal inflam-
mation (12). To determine whether sopE contributes to this
inflammation-induced growth advantage, we used groups ofmice
(C57BL/6) preconditioned by treatment with streptomycin and
infected with an SL1344 strain marked with an antibiotic resis-
tance cassette (phoN::Kan, CAL63), here referred to as the wild
type, or with an isogenicmutant lacking the sopE gene (phoN::Kan
sopE, CAL88). Four days after infection, the colon contents of
mice infected with the sopE-carrying wild-type strain (CAL63)
contained significantly higher numbers (P 0.05) of S. Typhimu-
rium than the colon contents of mice infected with the isogenic
sopE mutant (CAL88) (Fig. 1A), suggesting that the presence of
SopE significantly enhances the ability of S. Typhimurium SL1344
to grow in the intestinal lumen. This is the first time SopE has been
shown to enhance luminal growth of S. Typhimurium in the in-
flamed gut.
SopE enhances iNOS expression. One mechanism by which
S. Typhimurium can edge out competing microbes in the in-
flamed intestine is growth by anaerobic tetrathionate respiration
(15). To test whether SopE enhances the growth advantage con-
ferred by tetrathionate respiration, we infected streptomycin-
pretreated mice (C57BL/6) with an equal mixture of the SL1344
wild type (CAL63) and an isogenic mutant defective for tetrathio-
nate respiration (ttrAmutant, CAL66). Surprisingly, both strains
were recovered in similar numbers from colon contents 4 days
after infection (data not shown), indicating that tetrathionate res-
piration did not enhance the luminal growth of an S. Typhimu-
rium SopE lysogen. Similar results were obtained with geneti-
cally resistant (CBA/J) mice, which develop intestinal
inflammation slowly, within 1 to 2 weeks after S. Typhimurium
infection in the absence of streptomycin pretreatment. The S. Ty-
phimurium SL1344 wild type (CAL63) and its isogenic ttrA mu-
tant (CAL66) were recovered in similar numbers from the feces
over time (see Fig. S1 in the supplemental material). In contrast,
an S. Typhimurium strain naturally lacking the SopE prophage
(IR715) was recovered from fecal contents of CBA mice in signif-
icantly higher numbers than its isogenic ttrA mutant (SW661)
starting as early as day 5 after infection and continuing through-
out the remainder of the experiment (see Fig. S1 in the supple-
mental material).
FIG 1 The sopE gene induces iNOS expression and enhances the growth of S. Typhimurium in the intestine. Groups of streptomycin-pretreated mice were
infected with the SL1344 wild type (CAL63, sopE) or a sopEmutant (CAL88, sopE). Groups ofmice were euthanized at the indicated time points. For all groups,
n 4 except for the day 2 sopE group (n 3) (a) Analysis of bacterial numbers in the colon contents. Boxes in whisker plots represent the second and third
quartiles, while lines indicate the first and fourth quartiles. (B)Nos2mRNA levels in themucosawere quantified by real-timePCR. Bars represent geometricmean
Nos2 copy numbers per 100 copies of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) mRNA  the standard errors. (C) Levels of iNOS protein in the
mucosa frommice infected with sopE (lanes 1 to 4) or sopEmutant (lanes 5 to 8) strains were determined byWestern blotting (top panel). Detection of tubulin
by Western blotting served as a loading control (bottom panel). Each lane represents protein extracts isolated from one animal. Molecular masses of standard
proteins are indicated on the right. (D) Quantification of iNOS levels in Western blot assays by densitometry. Each square represents the intensity of the iNOS
signal divided by the intensity of the tubulin signal from one animal. Significance is based on the two-tailed Student t test. *, P 0.05.
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To further characterize the role of SopE during infection, we
analyzed the cecal immune response elicited by S. Typhimurium
strain SL1344 in the mouse colitis model. We noticed that the
SL1344 wild type (CAL63) induced Nos2 gene expression at sig-
nificantly higher levels than a sopEmutant (CAL88) at day 3 after
the infection of streptomycin-pretreated C57BL/6 mice (Fig. 1B),
although theNos2mRNA levels in the two groups were similar at
day 4 after infection. Nos2 encodes inducible nitric oxide (NO)
synthase (iNOS), which was present at significantly (P  0.05)
higher levels in the cecal mucosa 3 days after infection with the
wild type (CAL63) than after infection with a sopE mutant
(CAL88), as shown by immunoblotting (Fig. 1C) followed by
quantification by densitometry (Fig. 1D). Thus, the SopE-
mediated growth advantage observed 4 days after infection
(Fig. 1A) was preceded by a SopE-mediated increase in iNOS ex-
pression at day 3 after infection (Fig. 1B to D).
Nitrate is a negative regulator of tetrathionate respiration.
The activity of iNOS generates NO, which reacts with reactive
oxygen species (ROS) to form peroxynitrite (ONOO), a bacteri-
cidal reactive nitrogen species that quickly isomerizes to harmless
nitrate (NO3) (16). Nitrate is the preferred anaerobic electron
acceptor of Salmonella serotypes (17), presumably because the
relatively high standard redox potential (E0) of the nitrate-nitrite
redox couple (E0  433 mV) makes this electron acceptor ener-
getically favorable over the tetrathionate-thiosulfate couple,
which has a lower E0 (170 mV) (18). To test whether the presence
of nitrate is sufficient to suppress the growth advantage conferred
by tetrathionate respiration, mucin broth containing tetrathion-
ate and various concentrations of nitrate was inoculated with an
equalmixture of theKanr SL1344wild-type strain (CAL63) and an
isogenic carbenicillin-resistant (Carbr) ttrAmutant (CAL66). Ad-
dition of nitrate diminished the growth advantage conferred by
tetrathionate respiration in mucin broth containing tetrathionate
(Fig. 2A). These data suggested that in the presence of the ener-
getically preferred nitrate, the growth benefit conferred by tetra-
thionate respiration was diminished.
SopE changes ttrA gene expression during infection. One
possible scenario to explain the above observations is that SopE-
induced expression of iNOS in the cecal mucosa generates nitrate,
which in turn suppresses the expression of tetrathionate utiliza-
tion genes (ttrBAC) in the inflamed gut. To test this idea, we ex-
tracted bacterial RNA from the intestinal contents of mice 4 days
after infection with the SL1344 wild-type strain (CAL63) or with
an isogenic sopEmutant (CAL88) (mouse colitis model). Relative
levels of expression of the ttrA mRNA, which encodes the large
subunit of the tetrathionate reductase complex, were determined
by quantitative real-time PCR and normalized to the abundance
of S. Typhimurium 16S rRNA (15). Remarkably, expression of
ttrA was significantly lower in the SopE-expressing SL1344 wild
type (CAL63) than in the sopE mutant (CAL88) (Fig. 2B). These
data suggested that the presence of the sopE gene markedly re-
duced the expression of ttrA in luminal S. Typhimurium in vivo.
SopE enhances nitrate respiration-dependent growth of
S. Typhimurium. S. Typhimuriumcanutilize nitrate as a terminal
electron acceptor (17, 19). We therefore reasoned that the intesti-
nal growth advantage conferred by SopE (Fig. 1A)might be due to
anaerobic nitrate respiration. To test this hypothesis, we generated
a nitrate respiration-deficient mutant of SL1344. Three operons,
including narGHJI, narZYWV, and napFDAGHBC, contribute to
nitrate reductase activity in S. Typhimurium (20, 21). We dis-
rupted the narG, narZ, and napA genes in SL1344 to create a mu-
tant (CAL55) that completely lacked respiratory nitrate reductase
activity (Fig. 3A). Anaerobic coculture of the Kanr SL1344 wild
type (CAL63) with the isogenic Carbr narG narZ napA mutant
(CAL64) in mucin broth resulted in enrichment for the wild type
when the medium was supplemented with nitrate but not when
nitrate was absent (Fig. 3B).
To investigate whether nitrate respiration genes confer a
growth benefit in the inflamed intestine, we used themouse colitis
model and infected C57BL/6 mice with an equal mixture of the
SL1344 wild-type strain (CAL63) and the isogenic, nitrate
respiration-deficient mutant (narG narZ napA mutant, CAL64).
S. Typhimurium infection resulted in acute intestinal inflamma-
tion (Fig. 4A and B) and markedly increased levels of mRNAs for
genes that encode proinflammatory cytokines (keratinocyte-
FIG 2 Inhibition of tetrathionate respiration by nitrate and SopE. (A) Mucin
broth containing the indicated concentrations of nitrate and tetrathionate was
inoculated with an equal mixture of the SL1344 wild-type strain (wt, CAL63)
and a ttrAmutant (CAL66). Bacterial numbers were determined after 16 h of
anaerobic growth. Bars represent geometric means of the competitive index
the standard errors. Results are averages of three independent experiments. (B)
Groups of streptomycin-pretreatedmice (n 4 per group) were infected with
the SL1344 wild type (CAL63, sopE) or a sopE mutant (CAL88, sopE), and
bacterial RNA was extracted from cecal contents 4 days after infection. The
relative levels of ttrAmRNA were quantified by real-time PCR, normalized to
the abundance of S. Typhimurium 16S rRNA, and expressed as n-fold differ-
ences from the ttrA mRNA levels present in the SL1344 wild type (CAL63,
sopE). Bars represent geometric means  standard errors. Significance is
based on the two-tailed Student t test. **, P 0.01; *, P 0.05; ns, P 0.05.
FIG 3 Inactivation of nitrate reductases in S. Typhimurium. (A) Detection of
nitrate reductase activity in the S. Typhimurium wild type (SL1344) and a
narGnarZ napAmutant (CAL59). Briefly, the nitrate reductase assaymeasures
the reduction of nitrate to nitrite with methyl viologen as an electron donor.
Nitrate is added to the reaction medium containing lysed bacterial cells, and
nitrite (from nitrate reductase activity) is measured on the basis of its forma-
tion of a colored azo compound, which is quantified with a spectrophotome-
ter. (B) Mucin broth was inoculated with an equal mixture of the SL1344
wild-type strain (wt, CAL63) and a narG narZ napA mutant (CAL64). Com-
petitive indices for anaerobic growth in mucin broth with () or without ()
nitrate are shown. Bars represent geometricmeans standard errors. The data
are from three independent experiments. Significance is based on the two-
tailed Student t test. **, P 0.01.
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derived chemokine [KC], tumor necrosis factor alpha, and
gamma interferon [IFN-]) (Fig. 4C). Four days after infection,
the SL1344 wild-type strain (CAL63) was recovered in higher
numbers than the narG narZ napA mutant (CAL64) (Fig. 4D).
Similar results were obtained in the absence of streptomycin pre-
treatment when genetically resistant (CBA/J) mice were infected
with an equal mixture of CAL63 and CAL64. Outgrowth of the
nitrate respiration-competent strain (CAL63) was observed start-
ing day 16 after infection in this model (see Fig. S2 in the supple-
mental material).
Interestingly, when streptomycin-pretreated C57BL/6 mice
were infectedwith an equalmixture of a Kanr SL1344 sopEmutant
(CAL88) and a Carbr sopE narG narZ napAmutant (CAL89), the
growth advantage conferred by nitrate respiration was signifi-
cantly (P  0.01) diminished (Fig. 4D). Collectively, these data
suggested that the presence of the sopE gene significantly en-
hanced the luminal growth advantage conferred by nitrate respi-
ration genes.
S. Typhimurium causes intestinal inflammation by deploying
T3SS-1 for epithelial invasion and T3SS-2 to promote macro-
phage survival (14, 22, 23). Inactivation of T3SS-1 (through a
mutation in invA) and T3SS-2 (through a mutation in spiB) ren-
ders S. Typhimurium unable to trigger intestinal inflammation
(24). To determine whether nitrate respiration supports luminal
growth in the absence of inflammation, streptomycin-pretreated
C57BL/6 mice were infected with an equal mixture of a Kanr invA
spiBmutant (CAL86) and a Carbr invA spiB narG narZ napAmu-
tant (CAL85). Mice infected with this mixture neither developed
intestinal pathology (Fig. 4A and B) nor exhibited elevated levels
of mRNAs for genes that encode proinflammatory cytokines
(Fig. 4C). The equal recovery of both strains from colon contents
4 days after infection suggested that nitrate respiration provided
little growth benefit in the absence of intestinal inflammation
(Fig. 4D).
GrowthofS. Typhimurium is drivenbyhost-derivednitrate.
To further investigate the significance of SopE-mediated induc-
tion of iNOS expression during infection (Fig. 1B to D), wild-type
mice (C57BL/6) or iNOS-deficient mice (i.e., mice carrying amu-
tation in Nos2) were infected with an equal mixture of the Kanr
SL1344 wild-type strain (CAL63) and the isogenic, nitrate
respiration-deficient Carbr mutant (narG narZ napA mutant,
CAL64). As expected, iNOS expression was detected in wild-type
mice but not in iNOS-deficient mice (Fig. 5A) but both groups
exhibited similarly severe pathological changes 4 days after S. Ty-
phimurium infection (Fig. 5B and C). While a growth advantage
of the wild type (CAL63) over the narG narZ napA mutant
(CAL64) was observed in wild-type mice, no enrichment for the
S. Typhimurium wild-type strain was observed in Nos2-deficient
mice (Fig. 5D; P 0.01). These data suggested that host-derived
FIG 4 The sopE gene boosts nitrate respiration-dependent growth in vivo. Groups of streptomycin-pretreated mice (n  4 per group) were inoculated with
sterile medium (mock) or with equal mixtures of S. Typhimurium SL1344 derivatives (relevant genotypes are indicated), and organs were collected for analysis
4 days after infection. (A) Blinded histopathology scoring of cecal inflammation showing average scores (bars) and scores of individual animals (squares). (B)
Representative images of sections from the cecal mucosa. (C) Expression of proinflammatory markers in the cecal mucosa was determined by quantitative
real-time PCR analysis. Bars represent geometric mean KC-, tumor necrosis factor alpha-, and IFN--encoding (Kc, Tnfa, and Ifng, respectively) mRNA copy
numbers per 100,000 copies of glyceraldehyde 3-phosphate dehydrogenase (GAPDH)mRNA the standard errors. (D)Competitive indices of S. Typhimurium
strains recovered from the colon contents of infected mice. Bars represent geometric means standard errors. Significance is based on the two-tailed Student
t test. **, P 0.01.
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nitrate supports the nitrate respiration-dependent luminal
growth of S. Typhimurium.
Horizontal transfer of the SopE prophage enhances
growth by nitrate respiration. SopE is encoded by a mobile ge-
netic element, lysogenic SopE, that can be transferred horizon-
tally between different strains (5, 25). To recapitulate phage-
mediated horizontal transfer of the sopE gene, we determined how
intestinal growth of S. Typhimurium IR715 is altered by lysogeni-
zation with SopE. We infected mice with an equal mixture of
IR715 with an isogenic nitrate respiration-deficient mutant
(IR715 narG narZ napA mutant, CAL50) (mouse colitis model).
Four days after infection, mice exhibited acute intestinal inflam-
mation (Fig. 6A and B) and elevated levels of mRNAs for genes
that encode proinflammatory cytokines (Fig. 6C). Nitrate respi-
ration conferred a small growth advantage, as indicated by the
recovery of higher numbers of the S. Typhimurium wild type
(IR715) than of the isogenic nitrate respiration-deficient mutant
(IR715 narG narZ napA mutant, CAL50) (Fig. 6D). This nitrate
respiration-dependent growth advantage was not observed in
mice infected with an equal mixture of a nalidixic acid-resistant
(Nalr) IR715 invA spiBmutant (SPN452) and an IR715 invA spiB
narG narZ napA Carbr mutant (CAL87) (Fig. 6D), presumably
because these strains failed to elicit intestinal inflammation
(Fig. 6A to C).
We next infectedmice with an equalmixture of IR715 carrying
the SopE prophage (CAL99) and an isogenic nitrate respiration-
deficientmutant (IR715 SopE narG narZ napAmutant, CAL98)
(mouse colitis model). The growth benefit conferred by nitrate
respiration genes was significantly (P  0.05) greater in strains
lysogenized by the SopE prophage (CAL99 versus CAL98) than
in strains lacking the SopE prophage (IR715 versus, CAL50)
(Fig. 6D). These data suggested that horizontal transfer of SopE
significantly enhanced the luminal growth advantage conferred by
nitrate respiration in themouse colitis model. To exclude the pos-
sibility that other genes carried by the SopE prophage contrib-
uted to the enhancement of S. Typhimurium growth by nitrate
respiration, we repeated the experiment after deleting the sopE
gene. Mice were infected with an equal mixture of IR715 carrying
a SopE prophage derivative in which the sopE gene had been
deleted (IR715 SopE sopE mutant, CAL102) and an isogenic
nitrate respiration-deficient mutant (IR715 SopE sopE narG
narZ napA mutant, CAL103) (mouse colitis model). Deletion of
the sopE gene (CAL102 versus CAL103) reduced the luminal
growth advantage conferred by nitrate respiration to levels ob-
served in strains lacking the SopE prophage (IR715 versus,
CAL50) (Fig. 6D). The reduced competitive advantage was not
due to lessened inflammation, as both the histopathology scores
and levels of inflammatory cytokines of the groups were similar
(Fig. 6A to C).
Taken together, these results indicated that SopE-mediated
horizontal transfer of the sopE gene could increase the luminal
abundance of S. Typhimurium by boosting growth through ni-
trate respiration.
DISCUSSION
SopE is a T3SS-1 effector protein (26) that enhances intestinal
inflammation during S. Typhimurium infection (9, 10) by activat-
ing caspase 1, which in turn cleaves the immature forms of
interleukin-1 (IL-1) and IL-18 into biologically active cyto-
kines (7, 8). During S. Typhimurium infection, IL-18 contributes
to the early production of IFN- (27), a cytokine that is a potent
inducer of iNOS expression (28–31). Here we show that the pres-
ence of the sopE gene resulted in a significant increase in mucosal
iNOS production 3 days after S. Typhimurium infection in the
mouse colitismodel.NOgenerated by iNOS can reactwithROS to
form peroxynitrite (ONOO), which isomerizes to nitrate
FIG5 Nitrate driving anaerobic respiration is host derived. Groups (n 4) of streptomycin-pretreatedwild-type (WT)mice (C57BL/6) or iNOS-deficientmice
(Nos2) were inoculated with an equal mixture of an S. Typhimurium SL1344 wild-type strain (CAL63) and a narG narZ napAmutant (CAL64), and organs were
collected 4 days after infection. (A) Levels ofmucosal iNOS protein inwild-type (lanes 1 to 4) and iNOS-deficientmice (lanes 5 to 8) were determined byWestern
blotting (top). Detection of tubulin by Western blotting served as a loading control (bottom). Each lane represents protein extracts isolated from one animal.
Molecular masses (kilodaltons [kd]) of standard proteins are indicated on the right. (B) Representative images of sections from the cecal mucosa. (C) Blinded
histopathology scoring of cecal inflammation showing average scores (bars) and scores of individual animals (squares). (D) Competitive indices of S. Typhi-
murium strains recovered from the colon contents of infected mice. Bars represent geometric means standard errors. Significance is based on the two-tailed
Student t test. **, P 0.01.
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(NO3) (16), a terminal electron acceptor that can promote the
growth of S. Typhimurium by anaerobic nitrate respiration (17,
19). The elevated mucosal iNOS production observed 3 days after
infection was followed the next day by a nitrate respiration-
dependent luminal growth advantage of sopE-positive S. Typhi-
murium. This nitrate respiration-dependent luminal growth ad-
vantage was abrogated in iNOS-deficient mice. The picture
emerging from these data is that SopE-dependent iNOS expres-
sion generates host-derived nitrate, which in turn boosts the lu-
minal growth of S. Typhimurium in the inflamed intestine
through nitrate respiration (Fig. 7).
The sopE gene is carried by a bacteriophage, termed SopE (3),
that is absent from most S. Typhimurium isolates (4). The pres-
ence of SopE in an S. Typhimurium clone that caused an epi-
demic in cattle and humans in Europe in the 1980s suggests that
the fitness of this epidemic clone might have been increased by
phage-mediated horizontal transfer of the sopE gene (5). Here we
show that transfer of SopE into a SopE-negative S. Typhimu-
rium isolate (ATCC 14028) increased its fitness by conferring a
nitrate respiration-dependent luminal growth advantage.
In Escherichia coli, genes for anaerobic respiration are subject
to a hierarchical control that ensures that the respiratory electron
acceptor with the most positive E0 is used preferentially (32–38).
The nitrate-nitrite redox couple is a terminal electron acceptor
with a higher E0 (433 mV) (39) than the tetrathionate-thiosulfate
couple (E0 170mV) (18).Herewe show that nitrate is a negative
regulator of anaerobic tetrathionate respiration in vitro. Further-
more, the presence of the sopE gene significantly reduced the ex-
pression of tetrathionate respiration genes in the luminal S. Ty-
phimurium population in vivo. This hierarchical control of genes
involved in anaerobic respiration might ensure that the energeti-
cally preferred terminal electron acceptor is used preferentially to
maximize the growth rate in the competitive environment of the
large bowel.
The observation that tetrathionate provides a growth advan-
tage in the inflamed intestine (40) is not germane to host interac-
tions of the majority of the members of the family Enterobacteri-
aceae, because tetrathionate respiration is a signature trait
historically used to differentiate Salmonella serotypes from most
other bacteria (41). In contrast, the concept that nitrate respira-
tion can provide a growth benefit during intestinal inflammation
is relevant to other host-microbe interactions, since nitrate reduc-
FIG 6 Horizontal transfer of the SopE prophage boosts nitrate respiration-dependent growth in vivo. Groups of streptomycin-pretreated mice (the number
of mice in each group is shown in panel A) were inoculated with sterile medium (mock) or with equal mixtures of S. Typhimurium ATCC 14028 derivatives
(relevant genotypes are indicated), and organs were collected for analysis 4 days after infection. (A) Blinded histopathology scoring of cecal inflammation
showing average scores (bars) and scores of individual animals (squares). (B) Representative images of sections from the cecal mucosa. (C) Expression of
proinflammatorymarkers in the cecal mucosa was determined by quantitative real-time PCR analysis. Bars represent geometric means of n-fold changes in KC-,
tumor necrosis factor alpha-, and IFN--encoding (Kc,Tnfa, and Ifng, respectively)mRNA levels overmRNA levels inmock-infectedmice the standard errors.
(D) Competitive indices (CI) of S. Typhimurium strains recovered from the colon contents of infectedmice. Bars represent geometric means standard errors.
Significance is based on the two-tailed Student t test. *, P 0.05; **, P 0.01. WT, wild type.
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tases are widely conserved among the Proteobacteria. For example,
nitrate respiration enhances the ability of Campylobacter jejuni to
colonize the chicken cecum (42). In the genitourinary tract,Neis-
seria gonorrhoeaehas been hypothesized to use nitrite as a terminal
electron acceptor to survive in anoxic environments alongside
strict anaerobes (43). Finally, nitrate respiration has been postu-
lated to contribute to the successful colonization of anoxic mi-
croenvironments in the respiratory tract by Mycobacterium bovis
and Pseudomonas aeruginosa (44, 45). However, this is the first
study to find a direct effect of a T3SS effector protein, SopE, in
manipulating the host to provide a terminal electron acceptor for
use in respiration. The degree to which other bacteria may use
effector proteins or other virulence factors to manipulate host
production of terminal electron acceptors will be an exciting area
of future research.
MATERIALS AND METHODS
Bacterial culture conditions. For the Escherichia coli and S. Typhimu-
rium strains used in this study, see Table S1 in the supplemental material.
Strains were routinely grown in LB broth (10 g/liter tryptone, 5 g/liter
yeast extract, 10 g/liter) or on LB plates (15 g/liter agar) with the appro-
priate antibiotic at the following concentrations: Carb, 0.1 mg/ml; Cm,
0.03mg/ml; Kan, 0.1mg/ml; Nal, 0.05mg/ml; tetracycline (Tet), 0.02mg/
ml.
Transduction using phage P22.Once singlemutations were obtained
in an S. Typhimurium strain, phage lysates were generated.We incubated
1ml of an overnight culture of the strain of interest with 4ml of P22 broth
(LB broth supplemented with 1	 Eminimal medium [46], 0.2% glucose,
and 1010 to 1011 PFU/ml P22 HT-int) overnight at 37°C. Debris was re-
moved by centrifugation at 10,000 	 g for 5 min, and the phage-
containing supernatant was mixed with chloroform (20% final volume)
and stored at 4°C. To transfer mutations between strains, diluted phage
lysate containing the mutation of interest was incubated for 1 h at room
temperature with an overnight culture of the recipient bacterial strain.
The bacteria were then spread onto plates with the appropriate antibiotic.
Resulting colonies were streaked onto Evans blue uranine agar plates
(10 g/liter tryptone, 5 g/liter yeast extract, 5 g/liter NaCl, 2.5 g glucose,
15 g/liter Difco agar, 0.00125% Evans blue solution, 0.5% K2HPO4,
0.0025% sodium fluorescein) to select for nonlysogenic colonies. The
sensitivity of the resulting strains to reinfection with P22 was determined
by cross-streaking of the bacterial strain with P22 H5.
Construction of S. Typhimurium mutants. To construct the napA
mutant CAL46, as well as the narZ mutant CAL40, approximately 1-kb
regions upstream and downstream of either napA or narZ were PCR am-
plified (see Table S2 in the supplemental material) and digested with XbaI
(New England Biolabs). The two regions flanking each target gene were
ligated and PCR amplified to obtain an approximately 2-kb region that
was inserted into pCR2.1 with a TOPO cloning kit (Invitrogen), creating
plasmids pCAL3 and pCAL1, respectively. The insertions were then se-
quenced. The plasmids were next digested with SphI to excise the napA or
narZ flanking regions, which were then inserted into suicide plasmid
pRDH10 to obtain pCAL9 and pCAL10, respectively. These plasmids
were propagated in E. coli DH5 pir. A Kanr cassette from pUCKSAC
was inserted into the XbaI restriction site between the flanking regions to
create pCAL11 and pCAL12, respectively. E. coli S17-1 pir was trans-
formed with the resulting plasmids and subsequently used for conjuga-
tion. Single homologous recombination events were selected for by
growth on Kan and Cm plates. To select for strains that had lost the
integrated plasmid, leaving the Kanr sequence in place of the target gene,
we used sucrose selection. For sucrose selection, overnight cultures of
bacteria were grown in LB broth without antibiotics, diluted, spread onto
sucrose plates (5% sucrose, 8 g/liter nutrient broth, 15 g/liter agar), and
then incubated for 16 h at 30°C. Sucrose-sensitive andKans Cms strains in
which the napA or narZ gene had been replaced with the Kanr cassette
were termed CAL42 and CAL34, respectively. To generate nonpolar mu-
tants, E. coli S17-1 pir was transformed with either pCAL9 or pCAL10
and conjugated with CAL42 and CAL34, respectively. Sucrose selection
was performed as described above, and Kans Cms strains in which the
napA or narZ gene had been deleted were named CAL46 and CAL40,
respectively. Nonpolar mutations were confirmed by PCR. The napA
andnarZmutationswere transientlymarkedwithCmr by reintroducing
pCAL9 or pCAL10 into the chromosome of CAL46 and CAL40 to create
CAL117 and CAL45, respectively.
To construct the narG mutant CAL27, an approximately 500-bp re-
gion within the narG sequence was PCR amplified and digested with the
restriction enzymes XbaI and SphI. The digested fragment was subse-
quently cloned into pGP704 and propagated in E. coli S17-1 pir. The
resulting plasmid, pCAL5, was introduced into the IR715 chromosome by
conjugation, selecting for single homologous recombination events by
plating on plates containing Carb. Mutations were confirmed via PCR.
To generate a nonpolar deletion in spiB, E. coli S17-1 pir was trans-
formed with pSPN56 and conjugated with SPN450. Integration of
pSPN56 into SPN450was selected for by plating onLB containingCmand
Nal. Sucrose selection was used to select for the loss of pSPN56. Colonies
were screened for sensitivity to Cm andKan, and a colony exhibiting both
phenotypes was confirmed by PCR to contain an unmarked spiB locus,
yielding SPN456. To enable transduction of the unmarked spiB deletion,
pSPN56 was integrated into SPN456 by conjugation as described above,
resulting in a merodiploid spiB state flanking the integrated plasmid, a
state that was maintained by selection for Cmr. A transconjugant exhib-
iting Cmr and loss of the PCR product from unmarked spiB amplifica-
tion was termed SPN458 (spiB::pSPN56).
To construct the sopE mutant SW976, DNA regions upstream and
downstream of sopEwere PCR amplified and digested with XbaI. The two
flanking regions were ligated, PCR amplified, and cloned into pRDH10
using BamHI restriction enzyme sites to create pSW245. To create
FIG 7 Model of the chain of events by which SopE boosts nitrate respiration-
dependent growth of S. Typhimurium in the inflamed intestine. For an expla-
nation, see the text. DUOX2, dual-oxidase 2 of epithelial cells; NOX1,NADPH
oxidase 1 of epithelial cells; PHOX, NADPH oxidase of phagocytes.
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pSW246, a Kanr cassette was cloned into the XbaI site between the two
sopE flanking regions in pSW245. These plasmids were conjugated from
E. coli S17-1pir into S. Typhimurium. Plasmid integration into the chro-
mosome was verified by PCR. The sopE gene in SL1344 was deleted by
introducing pSW246 into SL1344(pSW172) by conjugation, selecting for
exconjugants on LB plates containing Carb and Kan. To ensure stable
replication of the temperature-sensitive plasmid pSW172, conjugation
experiments involving SL1344(pSW172) were performed at 30°C.
pSW172 was subsequently cured by growth at 37°C. A Kanr Cms Carbs
strain indicated that sopE had been replaced with Kanr and was termed
SW975.
To create a nonpolar deletion of sopE, pSW245 was integrated into the
chromosome of SW975 by conjugation, selecting for concomitant Kanr
and Cmr. Sucrose selection was then used to obtain a Kans Cms strain
named SW976. The sopE deletion was marked with Cmr by conjugating
SW976 with E. coli S17-1 pir containing pSW245. The Cmr strain was
termed CAL74.
The narG::pCAL5, narZ::pCAL10, and napA::pCAL9 mutations
were transduced from CAL27, CAL45, andCAL117, respectively, into
IR715. pCAL10 and pCAL9 were removed via sucrose selection, and the
resulting strain was designated CAL50. The invA::Tetr and spiB::
pSPN56 mutations were transduced from SW562 and SPN458, respec-
tively, into CAL50, pSPN56 was removed via sucrose selection, and the
resulting strain was designated CAL87. The SopE prophage from
AJB719 was transduced into IR715 and CAL50 to yield strains CAL99 and
CAL98, respectively. CAL63 was created by transducing the phoN::Kanr
mutation into SL1344. The narG, napA, and narZmutations fromCAL27,
CAL45, and CAL117 were transduced into SL1344 and CAL63, and plas-
mids pCAL10 and pCAL9 were removed via sucrose selection to yield
either mutants defective for a single nitrate reductase (designated CAL65,
CAL51, and CAL67, respectively) or nitrate reductase-deficient mutants
(CAL59 and CAL64). The invA::Tetr and spiB::pSPN56 mutations were
transduced from SW562 and SPN458 into strains CAL63 and CAL64,
pSPN56 was removed via sucrose selection, and the resulting strains were
designated CAL86 and CAL85, respectively. Additionally, the sopE::
pSW245 mutation was transduced from CAL74 into strains CAL63,
CAL64, CAL98, and CAL99 and the integrated plasmid pSW245 was re-
moved via sucrose selection to create strains CAL88, CAL89, CAL102, and
CAL103, respectively. The ttrA::pSW171 mutation was transduced from
SW661 into CAL63 to yield CAL66.
Respiratorynitrate reductase assay.Bacterial overnight cultureswere
diluted 1:100 in LB broth containing 40 mMNaNO3 and grown statically
for 3 h at 37°C. The assay was performed as described previously (38).
Relative nitrate reductase activity was calculated as previously described
(38).
Competitive growth assays. Competition assays were performed in
mucin broth containing 0.25% type II porcine mucin (Sigma-Aldrich),
40 mM morpholinepropanesulfonic acid (MOPS) buffer, trace elements
(47) and magnesium sulfate (265 mg/liter) dissolved in sterile water. So-
dium tetrathionate (Sigma-Aldrich) or sodium nitrate (Sigma-Aldrich)
dissolved in sterile water was added at the indicated concentrations. A 1:1
ratio of two overnight bacterial strains at a final concentration of 1 	
105 CFU was used to inoculate 14 ml of mucin medium into a 15-ml
screw-top conical tube. Cultures were statically incubated at 37°C for 24 h
and then placed on ice. Bacterial numbers were determined by plating
serial dilutions on the appropriate antibiotics. In vitro competition assays
were performed in triplicate with different colonies.
Mouse experiments.The InstitutionalAnimalCare andUseCommit-
tee at the University of California, Davis, approved all animal experi-
ments. For the mouse colitis model, either wild-type C57BL/6J or iNOS-
deficient B6.129P2-Nos2tm1Lau/Jmice (Jackson Laboratories, BarHarbor,
ME) were given streptomycin at 20 mg/mouse in 0.1 ml sterile water
intragastrically 24 h prior to inoculation with bacteria as described previ-
ously (14). In competition experiments, a 1:1 ratio of competing strains at
a final concentration of 1	 108 CFU/mouse in 0.1 ml LB broth was given
intragastrically. In single infections, 1	 108 CFU/mouse of a single strain
in 0.1ml LB brothwas given intragastrically.Micewere sacrificed between
1 and 4 days after infection as indicated. Cecal tissue and cecal contents
were flash frozen and stored at 80°C. Colon contents were stored in
phosphate-buffered saline (PBS) on ice. CFU counts were determined by
plating dilutions of the inoculum or colon content on selective medium.
In the model of extended S. Typhimurium infection, wild-type CBA/J
mice (Jackson Laboratories) were intragastrically provided an inoculum
containing a 1:1 ratio of competing strains at a final concentration of 1	
108 CFU/mouse in 0.1 ml LB broth. Fecal pellets were collected between 1
and 28 days postinfection as indicated and stored in PBS on ice. At the end
of the experiment, mice were euthanized and colon contents were re-
moved and stored in PBS on ice. CFU counts were determined by plating
dilutions of the inoculum, fecal pellets, or colon content on selective me-
dium.
Histopathology. The distal segment of the cecum was fixed in 10%
buffered formalin phosphate and stained with hematoxylin and eosin. A
veterinary pathologist scored histopathological changes by blinded scor-
ing of sections by a scheme described previously (48).
Isolation of cecal RNA and proteins. Tissue was homogenized in a
Mini-Beadbeater (BioSpec Products, Bartlesville, OK), andRNA and pro-
tein were isolated by the TRI-Reagent method (Molecular Research Cen-
ter, Inc.) following the manufacturer’s protocol. DNA remaining in the
RNA isolation portion was removed using the DNA-free kit (Applied
Biosystems). RNA samples and protein extracts were stored at80°C or
20°C, respectively.
Quantification of mRNA levels. Isolated RNA was normalized to
100 ng/l and reverse transcribed using random hexamers and Moloney
murine leukemia virus reverse transcriptase (Applied Biosystems). Quan-
titative real-time PCR was performed using SYBR green (Applied Biosys-
tems) PCR mix and the appropriate primer sets (see Table S2 in the sup-
plemental material) at a final concentration of 0.25 mM. In cases where
n-fold changes were calculated, relative expression was compared to ei-
ther mock-infected cecal tissue for murine gene expression experiments
or to SopE-positive S. Typhimurium for bacterial gene expression analy-
sis. In cases where absolute values were calculated, a standard curve was
used. To create the standards, first we used a standard PCR to amplify the
target gene fragment with the quantitative reverse transcription (qRT)-
PCR primers and inserting it into pCR2.1 by using the TOPO cloning kit.
The resulting plasmids were sequenced. The plasmids were quantified to
create a set of standards ranging from 108 to 101 copies/l diluted in a
0.02-mg/ml yeast RNA (Sigma) solution. Each qRT-PCR was performed
in duplicate.
Analysis of cecal proteins. The concentration of mouse cecal protein
was measured using aMicro BCA protein assay kit (Pierce) in accordance
with the manufacturer’s instructions. A 0.05-mg sample of protein was
separated by SDS-PAGE and transferred to a polyvinylidene fluoride
membrane (Millipore). Three percent nonfat driedmilk and 0.1% Tween
20 (Bio-Rad) in a PBS solution were used as blocking agents. To detect
iNOS, a 1:1,500 dilution of the primary antibody (anti-mouse; BD Trans-
duction Laboratories) in PBS with 5% bovine serum albumin (BSA) was
added to the membrane. As a loading control, /-tubulin was detected
with a 1:5,000 dilution of the primary antibody (anti-rabbit; Cell Signal-
ing) in PBS with 5% BSA. The horseradish peroxidase (HRP)-conjugated
secondary antibody (Bio-Rad), either anti-mouse or anti-rabbit, was di-
luted 1:5,000 in blocking buffer and applied to the membrane. Protein
bands were visualized by applying 0.5 ml HRP substrate solution and
imaged with a UVP BioSpectrum Imaging System. Blot density quantifi-
cation was performed with the Labworks Image Acquisition and Analysis
Software (UVP version 4.6.00.0).
Statistics. The natural log of the data values was calculated before
statistical analysis. We used Student’s t test to assess significance and con-
sidered P values below 0.05 to be significant.
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